Financials GL Sciences Inc.

Equities

7705

JP3385850007

Office Equipment

Market Closed - Japan Exchange 02:00:00 2024-04-26 am EDT 5-day change 1st Jan Change
2,785 JPY 0.00% Intraday chart for GL Sciences Inc. +2.73% +10.34%

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 17,114 15,975 10,106 25,568 26,009 23,669
Enterprise Value (EV) 1 14,578 13,045 7,065 23,772 23,849 24,099
P/E ratio 9.8 x 7.96 x 6.19 x 11.3 x 9.31 x 6.76 x
Yield 1.8% 1.93% 3.05% 1.4% 1.78% -
Capitalization / Revenue 0.75 x 0.64 x 0.4 x 0.88 x 0.79 x 0.61 x
EV / Revenue 0.64 x 0.53 x 0.28 x 0.81 x 0.72 x 0.62 x
EV / EBITDA 4.54 x 3.35 x 1.85 x 4.75 x 3.98 x 3.16 x
EV / FCF -16 x 75 x 12.1 x -21.6 x 89.7 x -13.5 x
FCF Yield -6.25% 1.33% 8.28% -4.62% 1.12% -7.41%
Price to Book 0.9 x 0.78 x 0.47 x 1.07 x 0.97 x 0.79 x
Nbr of stocks (in thousands) 10,260 10,260 10,260 10,260 10,260 10,260
Reference price 2 1,668 1,557 985.0 2,492 2,535 2,307
Announcement Date 6/25/18 6/28/19 6/26/20 6/25/21 6/24/22 6/23/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 22,938 24,800 25,530 29,217 33,119 38,679
EBITDA 1 3,211 3,891 3,816 5,005 5,994 7,622
EBIT 1 2,418 2,989 2,716 3,847 4,807 6,034
Operating Margin 10.54% 12.05% 10.64% 13.17% 14.51% 15.6%
Earnings before Tax (EBT) 1 2,663 3,422 2,761 3,963 4,998 6,490
Net income 1 1,747 2,006 1,633 2,257 2,795 3,499
Net margin 7.62% 8.09% 6.4% 7.72% 8.44% 9.05%
EPS 2 170.3 195.5 159.2 220.0 272.4 341.0
Free Cash Flow 1 -911.2 174 584.8 -1,099 266 -1,786
FCF margin -3.97% 0.7% 2.29% -3.76% 0.8% -4.62%
FCF Conversion (EBITDA) - 4.47% 15.32% - 4.44% -
FCF Conversion (Net income) - 8.67% 35.81% - 9.52% -
Dividend per Share 2 30.00 30.00 30.00 35.00 45.00 -
Announcement Date 6/25/18 6/28/19 6/26/20 6/25/21 6/24/22 6/23/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 11,742 13,210 15,075 8,479 8,514 17,851 9,825 8,181 17,135 9,179
EBITDA - - - - - - - - - -
EBIT 1 1,200 1,735 2,150 1,260 1,264 2,734 1,603 1,079 2,536 1,495
Operating Margin 10.22% 13.13% 14.26% 14.86% 14.85% 15.32% 16.32% 13.19% 14.8% 16.29%
Earnings before Tax (EBT) 1 1,240 1,940 2,154 1,339 1,509 3,118 1,605 1,367 2,881 1,512
Net income 1 666 1,026 1,113 713 750 1,526 845 672 1,496 792
Net margin 5.67% 7.77% 7.38% 8.41% 8.81% 8.55% 8.6% 8.21% 8.73% 8.63%
EPS 2 64.92 100.0 108.5 69.49 73.12 148.8 82.34 65.56 145.8 77.24
Dividend per Share - - - - - - - - - -
Announcement Date 11/5/19 11/2/20 11/2/21 2/3/22 8/3/22 11/8/22 2/7/23 8/3/23 11/6/23 2/9/24
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - 430
Net Cash position 1 2,536 2,930 3,041 1,796 2,160 -
Leverage (Debt/EBITDA) - - - - - 0.0564 x
Free Cash Flow 1 -911 174 585 -1,099 266 -1,786
ROE (net income / shareholders' equity) 9.92% 10.7% 8.19% 10.7% 12% 13.4%
ROA (Net income/ Total Assets) 5.39% 6.06% 5.21% 6.7% 7.36% 8.03%
Assets 1 32,394 33,121 31,348 33,688 37,984 43,601
Book Value Per Share 2 1,844 1,990 2,085 2,328 2,612 2,913
Cash Flow per Share 2 484.0 528.0 574.0 620.0 596.0 639.0
Capex 1 1,956 1,968 1,341 3,305 2,751 3,100
Capex / Sales 8.53% 7.94% 5.25% 11.31% 8.31% 8.01%
Announcement Date 6/25/18 6/28/19 6/26/20 6/25/21 6/24/22 6/23/23
1JPY in Million2JPY
Estimates
  1. Stock Market
  2. Equities
  3. 7705 Stock
  4. Financials GL Sciences Inc.